Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors

GLIA

Volumn 49, Issue 2, 2005, Pages 288-300

  Shevozaki, Youichi ^a,b   Koizumi, Schuichi ^a   Ishida, Seiichi ^a   Sawada, Jun Ichi ^a   Ohno, Yasuo ^a   Inoue, Kazuhide ^a,b  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Astrocytes; ATP; Oxidative stress; P2Y1 receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 METHYLTHIOADENOSINE DIPHOSPHATE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE; ADENOSINE TRIPHOSPHATE; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; CALCIUM CHELATING AGENT; CYCLOHEXIMIDE; HYDROGEN PEROXIDE; NUCLEOSIDE; OXIDOREDUCTASE; PHOSPHOLIPASE C; PROTEIN SYNTHESIS INHIBITOR; PURINE P2Y1 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN INJURY; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA MICROARRAY; GENE CONTROL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HYDROGEN PEROXIDE; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXIDOREDUCTASES; PROTEIN SYNTHESIS INHIBITORS; RATS; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; UP-REGULATION;

EID: 13244272004     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20118     Document Type: Article

References (93)

1. Abbracchio MP, Burnstock G. 1994. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475.
2. Abbracchio MP, Ceruti S, Barbieri D, Franceschi C, Malorni W, Biondo L, Burnstock G, Cattabeni F. 1995. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun 213:908-915.
3. Agardh CD, Zhang H, Smith ML, Siesjo BK. 1991. Free radical production and ischemic brain damage: influence of postischemic oxygen tension. Int J Dev Neurosci 9:127-138.
4. Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF. 2000. Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem 74:1951-1960.
5. 2 receptor. Brain Res 952:31-37.
6. Akbar GK, Dasari VR, Webb TE, Ayyanathan K, Pillarisetti K, Sandhu AK, Athwal RS, Daniel JL, Ashby B, Barnard EA, Kunapulis SP. 1996. Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. J Biol Chem 271:18363-18367.
7. Altman FP. 1976. Tetrazolium salts: a consumer's guide. Histochem J 8:471-485.
8. Appel E, Kazimirsky G, Ashkenazi E, Kim SG, Jacobson KA, Brodie C. 2001. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis. J Mol Neurosci 17:285-292.
9. Araque A, Parpura V, Sanzgiri RP, Haydon PG. 1999a. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22:208-215.
10. Araque A, Sanzgiri RP, Parpura V, Haydon PG. 1999b. Astrocyte-induced modulation of synaptic transmission. Can J Physiol Pharmacol 77:699-706.
11. Araque A, Carmignoto G, Haydon PG. 2001. Dynamic signaling between astrocytes and neurons. Annu Rev Physiol 63:795-813.
12. 1 purinoceptor. Biochem Biophys Res Commun 218:783-788.
13. Balcz B, Kirchner L, Cairns N, Fountoulakis M, Lubec G. 2001. Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease. J Neural Transm Suppl;(61):193-201.
14. Behan WM, Stone TW. 2002. Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists. Br J Pharmacol 135:1435-1442.
15. Brambilla R, Burnstock G, Bonazzi A, Ceruti S, Cattabeni F, Abbracchio MP. 1999. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br J Pharmacol 126:563-567.
16. Braun N, Lenz C, Gillardon F, Zimmermann M, Zimmermann H. 1997. Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase. Brain Res 766:213-226.
17. Braun N, Zhu Y, Krieglstein J, Culmsee C, Zimmermann H. 1998. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 18:4891-4900.
18. Butterfield DA, Boyd-Kimball D, Castegna A. 2003. Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration. J Neurochem 86:1313-1327.
19. Ceruti S, Franceschi C, Barbieri D, Malorni W, Camurri A, Giammarioli AM, Ambrosini A, Racagni G, Cattabeni F, Abbracchio MP. 2000. Apoptosis induced by 2-chloro-adenosine and 2-chloro-2′-deoxy-adenosine in a human astrocytoma cell line: differential mechanisms and possible clinical relevance. J Neurosci Res 60:388-400.
20. Charles AC, Merrill JE, Dirksen ER, Sanderson MJ. 1991. Intercellular signaling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 6:983-992.
21. Chen J, Backus KH, Deitmer JW. 1997. Intracellular calcium transients and potassium current oscillations evoked by glutamate in cultured rat astrocytes. J Neurosci 17:7278-7287.
22. Ciccarelli R, Ballerini P, Sabatino G, Rathbone MP, D'Onofrio M, Caciagli F, Di Iorio P. 2001. Involvement of astrocytes in purine-mediated reparative processes in the brain. Int J Dev Neurosci 19:395-414.
23. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. 1990. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 247:470-473.
24. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI. 2000. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275:19439-19442.
25. Desagher S, Glowinski J, Premont J. 1996. Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553-2562.
26. Di Iorio P, Kleywegt S, Ciccarelli R, Traversa U, Andrew CM, Crocker CE, Werstiuk ES, Rathbone MP. 2002. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38:179-190.
27. Dubyak GR, el-Moatassim C. 1993. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265(3 Pt 1):C577-606.
28. Eftekharpour E, Holmgren A, Juurlink BH. 2000. Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31:241-248.
29. 2+ wave propagation in dorsal spinal cord astrocytes. J Neurosci 20:2800-2808.
30. Finkbeiner S. 1992. Calcium waves in astrocytes-filling in the gaps. Neuron 8:1101-1108.
31. Forrest GL, Gonzalez B. 2000. Carbonyl reductase. Chem Biol Interact 129:21-40.
32. Franke H, Grosche J, Schadlich H, Krugel U, Allgaier C, Illes P. 2001a. P2X receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 108:421-429.
33. Franke H, Krugel U, Schmidt R, Grosche J, Reichenbach A, Illes P. 2001b. P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol 134:1180-1189.
34. Fredholm BB, Dunwiddie TV. 1988. How does adenosine inhibit transmitter release? Trends Pharmacol Sci 9:130-134.
35. Fumagalli M, Brambilla R, D'Ambrosi N, Volonte C, Matteoli M, Verderio C, Abbracchio MP. 2003. Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43:218-230.
36. Furuta A, Price DL, Pardo CA, Troncoso JC, Xu ZS, Taniguchi N, Martin LJ. 1995. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 146:357-367.
37. 2 receptors. J Neurosci 23:6728-6739.
38. 2+ influx into astrocytes. Proc Natl Acad Sci USA 87:3454-3458.
39. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB. 1999. ATP released from astrocytes mediates glial calcium waves. J Neurosci 19:520-528.
40. Hansson HA, Holmgren A, Norstedt G, Rozell B. 1989. Changes in the distribution of insulin-like growth factor I, thioredoxin, thioredoxin reductase and ribonucleotide reductase during the development of the retina. Exp Eye Res 48:411-420.
41. Haydon PG. 2001. Glia: listening and talking to the synapse. Nat Rev Neurosci 2:185-193.
42. 3 receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 21:55-63.
43. Ho C, Hicks J, Salter MW. 1995. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat. Br J Pharmacol 116:2909-2918.
44. Huang X, Cuajungco MP, Atwood CS, Moir RD, Tanzi RE, Bush AI. 2000. Alzheimer's disease, beta-amyloid protein and zinc. J Nutr 130(5 suppl):1488S-1492S.
45. 2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord. Neuroscience 86:913-923.
46. Inazu N, Ruepp B, Wirth H, Wermuth B. 1992. Carbonyl reductase from human testis: purification and comparison with carbonyl reductase from human brain and rat testis. Biochim Biophys Acta 1116:50-56.
47. Innocenti B, Parpura V, Haydon PG. 2000. Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes. J Neurosci 20:1800-1808.
48. Inoue K, Koizumi S, Nakazawa K. 1995. Glutamate-evoked release of adenosine 5′-triphosphate causing an increase in intracellular calcium in hippocampal neurons. NeuroReport 6:437-440.
49. 2+) signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447:247-260.
50. Jones PA, Smith RA, Stone TW. 1998. Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res 800:328-335.
51. Jurkowitz MS, Litsky ML, Browning MJ, Hohl CM. 1998. Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between protection and ATP preservation. J Neurochem 71:535-548.
52. Kim SG, Gao ZG, Soltysiak KA, Chang TS, Brodie C, Jacobson KA. 2003a. P2Y6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell Mol Neurobiol 23:401-418.
53. 4 nucleotide receptors. Biochem Pharmacol 65:923-931.
54. Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G. 2001. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa sub-units in brains of patients with Down syndrome and Alzheimer's disease. Life Sci 68:2741-2750.
55. Koizumi S, Inoue K. 1997. Inhibition by ATP of calcium oscillations in rat cultured hippocampal neurones. Br J Pharmacol 122:51-58.
56. 2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes. Life Sci 72:431-442.
57. Koizumi S, Fujishita K, Tsuda M, Shigemoto-Mogami Y, Inoue K. 2003. Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures. Proc Natl Acad Sci USA 100:11023-11028.
58. 2 production during ischemia and reperfusion: a microdialysis study in the gerbil hippocampus. Neurosci Lett 222:91-94.
59. 2Y purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol 129:927-936.
60. Lovell MA, Xie C, Gabbita SP, Markesbery WR. 2000. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28:418-427.
61. Lustig KD, Shiau AK, Brake AJ, Julius D. 1993. Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 90:5113-5117.
62. Lutz PL, Kabler S. 1997. Release of adenosine and ATP in the brain of the freshwater turtle (Trachemys scripta) during long-term anoxia. Brain Res 769:281-286.
63. 1 purinergic receptor in Alzheimer's disease. NeuroReport 11:3799-3803.
64. Neary JT, Kang Y, Bu Y, Yu E, Akong K, Peters CM. 1999. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J Neurosci 19:4211-4220.
65. Newman EA. 2003. Glial cell inhibition of neurons by release of ATP. J Neurosci 23:1659-1666.
66. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, Yong VW, Ransohoff RM, MacVicar BA. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21:7135-7142.
67. Parkinson FE, Sinclair CJ, Othman T, Haughey NJ, Geiger JD. 2002. Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions. Neuropharmacology 43:836-846.
68. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. 1994. Glutamate-mediated astrocyte-neuron signalling. Nature 369:744-747.
69. Pasti L, Volterra A, Pozzan T, Carmignoto G. 1997. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci 17:7817-7830.
70. Peakman MC, Hill SJ. 1994. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes. Br J Pharmacol 111:191-198.
71. i in hippocampal astrocytes in situ. J Neurochem 65:1515-1523.
72. Porter JT, McCarthy KD. 1996. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci 16:5073-5081.
73. Queiroz G, Meyer DK, Meyer A, Starke K, von Kugelgen I. 1999. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91:1171-1181.
74. Rozell B, Hansson HA, Luthman M, Holmgren A. 1985. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38:79-86.
75. 2+ waves trigger responses in microglial cells in brain slices. FASEB J 16:255-257.
76. Schubert P, Ogata T, Marchini C, Ferroni S, Rudolphi K. 1997. Protective mechanisms of adenosine in neurons and glial cells. Ann NY Acad Sci 825:1-10.
77. Schwarzschild MA, Xu K, Oztas E, Petzer JP, Castagnoli K, Castagnoli N Jr, Chen JF. 2003. Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson's disease. Neurology 61(11 suppl 6):S55-61.
78. Servitja JM, Masgrau R, Pardo R, Sarri E, Picatoste F. 2000. Effects of oxidative stress on phospholipid signaling in rat cultured astrocytes and brain slices. J Neurochem 75:788-794.
79. 2 receptors in cultured, non-transformed bovine ciliary epithelial cells. Curr Eye Res 16:1006-1016.
80. Shin CY, Choi JW, Ryu JR, Ko KH, Choi JJ, Kim HS, Lee JC, Lee SJ, Kim HC, Kim WK. 2002. Glucose deprivation decreases nitric oxide production via NADPH depletion in immunostimulated rat primary astrocytes. Glia 37:268-274.
81. Tabner BJ, Turnbull S, El-Agnaf O, Allsop D. 2001. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. Curr Top Med Chem 1:507-517.
82. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK. Exp Neurol 180:144-155.
83. Tokuyama Y, Kara M, Jones EM, Fan Z, Bell GI. 1995. Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun 211:211-218.
84. Twentyman PR, Luscombe M. 1987. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 56:279-285.
85. Verderio C, Matteoli M. 2001. ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J Immunol 166:6383-6391.
86. 2 in cultured human vascular endothelium. Cell Calcium 24:117-127.
87. 1 messenger RNA within the chick brain. Neuroscience 84:825-837.
88. Wieraszko A, Goldsmith G, Seyfried TN. 1989. Stimulation-dependent release of adenosine triphosphate from hippocampal slices. Brain Res 485:244-250.
89. Wirth H, Wermuth B. 1992. Immunohistochemical localization of carbonyl reductase in human tissues. J Histochem Cytochem 40:1857-1863.
90. Yamakuni H, Kawaguchi N, Ohtani Y, Nakamura J, Katayama T, Nakagawa T, Minami M, Satoh M. 2002. ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J Neuroimmunol 129:43-50.
91. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, Wu CP, Poo MM, Duan S. 2003. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971-982.
92. Zhang M, Zhong H, Vollmer C, Nurse CA. 2000. Co-release of ATP and ACh mediates hypoxic signalling at rat carotid body chemoreceptors. J Physiol 525(Pt 1):143-158.
93. Zimmermann H. 1996. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog Neurobiol 49:589-618.